The weird rigors of this process have not always protected

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
Quote:
The weird rigors of this process have not always protected the parties from politically disastrous nominees, like Barry Goldwater or George McGovern. But Goldwater and McGovern were both men of principle and experience and civic virtue, leading factions that had not yet come to full maturity. This made them political losers; it did not make them demagogues.

Trump, though, is cut from a very different cloth. He’s an authoritarian, not an ideologue, and his antecedents aren’t Goldwater or McGovern; they’re figures like George Wallace and Huey Long, with a side of the fictional Buzz Windrip from Sinclair Lewis’s “It Can’t Happen Here.”

No modern political party has nominated a candidate like this; no serious political party ever should.



Quote:
The Party Still Decides

Ross Douthat NYT MARCH 12, 2016

POLITICAL parties are mentioned nowhere in the Constitution, and the party nominating process offers few of the protections associated with the ideal of “one man one vote.” Voters in early states have far more influence than voters in later ones. Votes in hard-to-attend caucuses effectively count more than votes in high-turnout primaries. Some primaries are open to party loyalists; others to all comers. The rules that assign convention delegates are byzantine, the delegate selection process is various, and a few states rely on conventions and cut the voters out entirely.

As Donald Trump attempts to clamber to the Republican nomination over a still-divided opposition, there will be a lot of talk about how all these rules and quirks and complexities are just a way for insiders to steal the nomination away from him, in a kind of establishment coup against his otherwise inevitable victory.

We can expect to hear this case from Trump’s growing host of thralls and acolytes. (Ben Carson, come on down!) But we will also hear it from the officially neutral press, where there will be much brow-furrowed concern over the perils of party resistance to Trump’s progress, the “bad optics” of denying him the nomination if he arrives at the convention with the most delegates, the backlash sure to come if his uprising is somehow, well, trumped by the party apparatus.

Americans speak and think in the language of democracy, and so these arguments will find an audience, including among party leaders and delegates themselves.

But they cut against the deeper wisdom of the American political tradition. The less-than-democratic side of party nominations is a virtue of our system, not a flaw, and it has often been a necessary check on the passions (Trumpian or otherwise) that mass democracy constantly threatens to unleash.

That check has weakened with the decline of machines, bosses and smoke-filled rooms. But in many ways it remains very much in force — confronting would-be demagogues with complicated ballot requirements, insisting that a potential Coriolanus or a Sulla count delegates in Guam and South Dakota, asking men who aspire to awesome power to submit to the veto of state chairmen and local newspapers, the town meeting and the caucus hall.

The weird rigors of this process have not always protected the parties from politically disastrous nominees, like Barry Goldwater or George McGovern. But Goldwater and McGovern were both men of principle and experience and civic virtue, leading factions that had not yet come to full maturity. This made them political losers; it did not make them demagogues.

Trump, though, is cut from a very different cloth. He’s an authoritarian, not an ideologue, and his antecedents aren’t Goldwater or McGovern; they’re figures like George Wallace and Huey Long, with a side of the fictional Buzz Windrip from Sinclair Lewis’s “It Can’t Happen Here.” No modern political party has nominated a candidate like this; no serious political party ever should.

Because such figures speak — as Wallace did, and Long, and Ross Perot, and others — to real grievances, the process of dealing with them is necessarily painful, and often involves a third-party bid and a difficult reckoning thereafter. Trump would be no exception: Denying him the nomination would indeed be an ugly exercise, one that would weaken or crush the party’s general election chances, and leave the G.O.P. with a long hard climb back up to unity and health.

But if that exercise is painful, it’s also the correct path to choose. A man so transparently unfit for office should not be placed before the American people as a candidate for president under any kind of imprimatur save his own. And there is no point in even having a party apparatus, no point in all those chairmen and state conventions and delegate rosters, if they cannot be mobilized to prevent 35 percent of the Republican primary electorate from imposing a Trump nomination on the party.

What Trump has demonstrated is that in our present cultural environment, and in the Republican Party’s present state of bankruptcy, the first lines of defense against a demagogue no longer hold.

Because he’s loud and rich and famous, because he’s run his campaign like a reality TV show, because he’s horribly compelling and, yes, sometimes even right, Trump has come this far without many endorsements or institutional support, without much in the way of a normal organization, clearing hurdle after hurdle where people expected him to fall.

But the party’s convention rules, in all their anachronistic, undemocratic and highly-negotiable intricacy, are also a line of defense, also a hurdle, also a place where a man unfit for office can be turned aside.

So in Cleveland this summer, the men and women of the Republican Party may face a straightforward choice: Betray the large minority of Republicans who cast their votes for Trump, or betray their obligations to their country.

For a party proud of its patriotism, the choice should not be hard.

LK
CT 2 hours ago
The conservative elite were absolutely mute for eight years while the fear-mongers and the certifiable insulted, threatened and treated our current President with a level of disrespect never before seen in my lifetime. Just yesterday Dana Milbanks reported in the Washington Post that Republican leaders have announced that -- sight unseen -- they will not hold hearings or allow any administration officials to testify on behalf of the President's annual budget. Supreme Court replacement for Scalia, anyone?
https://www.washingtonpost.com/opinions/repub...truction...

So this idea that GOP is so patriotic that they will go all Jim Jones and commit mass political suicide at the convention to save the country from Herr Trump is some kind of bizarre, beyond-the-7-stages-of-grief fantasy.

This is a man that you were all more than pleased with not so very long ago (and none more so than Mitt Romney) when Trump was pushing the birther nonsense. You knew what he was then but as long as he only spewing venom at Obama, you all were fine with it.

Maybe you and Mitch McConnell can strap Donald and the other three to the roof of Mitt's car and drive to Canada....although it's doubtful the Canadians will let you in. They're much too sensible.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SAP Execution Can Steady Operations Beyond Spreadsheets

Updated Category News Views 114

Spreadsheets breed little kingdoms, and SAP is often left outside the gate. That is the operational mess Martin Rowan, managing partner at Reveal USA, Inc. in Naperville, is taking aim at in a Nov. 19, 2026 HelloNation feature. His central point is not terribly glamorous, but it is dead right: a company gets less stable when it uses SAP to explain yesterday's results...

Continue Reading
BBW Lawsuit Puts Guidance and Walmart Claims Under Lens

Updated Category News Views 65

A three-month slice of 2026 has landed Build-A-Bear in the sort of mess investors hate most: a securities complaint centered on whether management's upbeat messaging had already outrun the facts. The lawsuit targets purchases of BBW shares from May 28, 2026 through August 26, 2026, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 133

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading
MTI Adds Aviation Veterans as Acorn Builds MRO Plan

Updated Category News Views 5

Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...

Continue Reading
Birla Carbon's Rayong Bet Tightens Asian Supply Lines

Updated Category News Views 130

Rayong just became a much louder pin on Asia's industrial map. Birla Carbon has inaugurated a 120 kMT carbon black plant in Thailand, and the significance is bigger than a ribbon-cutting photo. This is a capacity-and-location move aimed squarely at the uncomfortable part of industrial supply chains: customers need material when they need it, not after it has spent weeks...

Continue Reading
Sleep Number’s Couples Pitch Has Some Fine Print Too

Updated Category News Views 52

A thermostat war in the bedroom is a lousy reason to buy the wrong mattress. Yet that is the mundane, very real problem Sleep Number is leaning into after Expert Consumers named it a leading 2026 choice for couples seeking personalized sleep comfort. The company’s argument is straightforward: two people sharing a bed should not have to share one firmness setting, or...

Continue Reading
West Virginia SEO Timelines Demand Patience, Not Hype

Updated Category News Views 11

A fresh website with no search footprint is not a race car; it is a pickup stuck in mud, and Sean O'Kelly's view of local SEO in West Virginia puts that inconvenient fact right on the table. Most businesses can expect measurable improvement after three to six months of consistent work, according to the HelloNation article. That is not a glamorous answer, but it is the...

Continue Reading
Cybersecurity's AI Tailwind Meets a Brutal Market Test

Updated Category News Views 89

Security software caught a bid while the rest of the tape was getting kicked down the stairs. That contrast is the whole story: investors saw Palo Alto Networks deliver a strong fiscal first quarter and raise its fiscal 2027 outlook, then decided cyber defense may be one of the few technology budgets companies cannot casually postpone. With AI helping attackers locate and...

Continue Reading
Gene Editing’s Steady Revenue Engine Is Taking Shape

Updated Category News Views 112

Gene editing is finally starting to look less like a science-fair moonshot and more like a working supply chain. That distinction matters. The latest market estimate puts the global gene editing market at $5.23 billion in 2026 and projects $8.49 billion by 2031, a 10.1% compound annual growth rate. Respectable growth, certainly, but the real investment story is not a...

Continue Reading
RMT’s 12.4% Discount Still Demands a Much Harder Look

Updated Category News Views 119

A $1.84 gap is staring RMT shareholders right in the face. As of October 31, 2026, Royce Micro-Cap Trust carried a net asset value of $14.82 per share while the market price sat at $12.98. That is roughly a 12.4% discount to NAV, and closed-end fund investors should never wave off a spread like that with a lazy shrug. It may be opportunity. It may also be the market...

Continue Reading

Top 5 Most Recently Viewed Articles

Raphael Bostic's Forecast for Interest Rate Cuts in 2024

Updated Category News Views 139

Fed's Bostic Discusses Future Interest Rate Cuts Atlanta Federal Reserve President Raphael Bostic has recently shared his insights regarding future interest rate adjustments. At a recent event in Atlanta, Bostic indicated that he has projected a further interest rate decrease of 25 basis points this year. This update follows his review of the central bank's recent...

Continue Reading
Boardwalktech Software to Showcase Innovations at Upcoming Event

Updated Category News Views 169

Boardwalktech Software Demonstrates Commitment to Innovation Boardwalktech Software Corp. (TSXV: BWLK) (OTCQB: BWLKF), recognized as a leader in the Intelligent Information Platform sector, has announced that their CEO and Chairman, Andrew Duncan, is set to present at the highly anticipated Planet MicroCap Showcase. This event, in partnership with MicroCapClub, serves as...

Continue Reading
Michael Saylor Advocates for U.S. Leadership in Cryptocurrency

Updated Category News Views 123

Michael Saylor's Vision for Digital Assets Michael Saylor, the co-founder of Strategy Inc. and a prominent advocate for Bitcoin, recently held discussions with key figures in the House Financial Services Committee. His conversations focused on strategies to position the United States as a leading authority in the world of Bitcoin and cryptocurrencies. The Digital Assets...

Continue Reading
Gents Doctor Unveils Insights on Testosterone Therapy and Health

Updated Category News Views 297

Gents Doctor Shares New Insights on Testosterone Therapy Gents Doctor, a well-known male health clinic led by Dr. Majid Sabour, MD, has recently unveiled two important blog posts that explore significant topics related to Testosterone Replacement Therapy (TRT). These posts are designed to inform men who are interested in improving their health through hormone...

Continue Reading
Promising Results from Phase III POLARIS-1 Study of Olverembatinib

Updated Category News Views 233

Exciting Developments in the Treatment of Ph+ ALL At the recent American Society of Hematology (ASH) meeting, cutting-edge research on Olverembatinib, a promising drug from Ascentage Pharma, highlighted its impressive efficacy for patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The findings from the Phase III...

Continue Reading